These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22401537)

  • 1. Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis.
    Willeke P; Becker H; Schlüter B; Pavenstäd H; Mickholz E; Wierichs C; Gaubitz M; Schotte H
    Scand J Rheumatol; 2012 May; 41(3):242-3. PubMed ID: 22401537
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate.
    Rigby W; Ferraccioli G; Greenwald M; Zazueta-Montiel B; Fleischmann R; Wassenberg S; Ogale S; Armstrong G; Jahreis A; Burke L; Mela C; Chen A
    Arthritis Care Res (Hoboken); 2011 May; 63(5):711-20. PubMed ID: 21557525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological treatment of rheumatoid arthritis: towards a more cost-effective re-treatment regimen using rituximab?
    Boumans MJ; Vos K; Gerlag DM; Tak PP
    Ann Rheum Dis; 2012 Mar; 71(3):472-3. PubMed ID: 21908451
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment.
    Lal P; Su Z; Holweg CT; Silverman GJ; Schwartzman S; Kelman A; Read S; Spaniolo G; Monroe JG; Behrens TW; Townsend MJ
    Arthritis Rheum; 2011 Dec; 63(12):3681-91. PubMed ID: 22127691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial.
    Tak PP; Rigby WF; Rubbert-Roth A; Peterfy CG; van Vollenhoven RF; Stohl W; Hessey E; Chen A; Tyrrell H; Shaw TM;
    Ann Rheum Dis; 2011 Jan; 70(1):39-46. PubMed ID: 20937671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can response duration after the first rituximab treatment be used in timing of rituximab retreatment?
    van Herwaarden N; van der Maas A; Jansen TL; Dutmer EA; Hartkamp A; van Riel PL; Kievit W; van den Bemt BJ; den Broeder AA
    Scand J Rheumatol; 2013; 42(3):251-2. PubMed ID: 23496283
    [No Abstract]   [Full Text] [Related]  

  • 7. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.
    Conti F; Ceccarelli F; Priori R; Iagnocco A; Signore A; Valesini G
    Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab treatment for persistent scleritis associated with rheumatoid arthritis.
    Iaccheri B; Androudi S; Bocci EB; Gerli R; Cagini C; Fiore T
    Ocul Immunol Inflamm; 2010 Jun; 18(3):223-5. PubMed ID: 20482403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of macrophage migration inhibitory factor in adult-onset Still's disease.
    Becker H; Gaubitz M; Domschke W; Willeke P
    Scand J Rheumatol; 2009; 38(1):69-71. PubMed ID: 18686192
    [No Abstract]   [Full Text] [Related]  

  • 10. Campylobacter fetus infection in three rheumatoid arthritis patients treated with rituximab.
    Meyer A; Theulin A; Chatelus E; Argemi X; Sordet C; Javier RM; Hansmann Y; Sibilia J; Gottenberg JE
    Ann Rheum Dis; 2012 Jun; 71(6):1094-5. PubMed ID: 22302315
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.
    Emery P; Fleischmann R; Filipowicz-Sosnowska A; Schechtman J; Szczepanski L; Kavanaugh A; Racewicz AJ; van Vollenhoven RF; Li NF; Agarwal S; Hessey EW; Shaw TM;
    Arthritis Rheum; 2006 May; 54(5):1390-400. PubMed ID: 16649186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen.
    Ezeonyeji AN; Isenberg DA
    Rheumatology (Oxford); 2012 Mar; 51(3):476-81. PubMed ID: 22096015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy in Poland].
    Samborski W; Buczek J; Bednarek A; Lewandowicz J; Kucharz E
    Pol Merkur Lekarski; 2010 Dec; 29(174):365-8. PubMed ID: 21298986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients.
    Valleala H; Korpela M; Möttönen T; Hienonen-Kempas T; Kauppi M; Hannonen P; Leirisalo-Repo M
    Scand J Rheumatol; 2009; 38(5):323-7. PubMed ID: 19585384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sickness and severe angioedema following rituximab therapy in RA.
    Kumar A; Khamkar K; Gopal H
    Int J Rheum Dis; 2012 Feb; 15(1):e6-7. PubMed ID: 22324965
    [No Abstract]   [Full Text] [Related]  

  • 16. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
    Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
    Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The quality of life in patients with rheumatoid arthritis treated with rituximab].
    Mazurov VI; Avlokhova SR
    Klin Med (Mosk); 2014; 92(12):42-8. PubMed ID: 25980298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
    De Benedetti F; Meazza C; Vivarelli M; Rossi F; Pistorio A; Lamb R; Lunt M; Thomson W; Ravelli A; Donn R; Martini A;
    Arthritis Rheum; 2003 May; 48(5):1398-407. PubMed ID: 12746913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of small-dose glucocorticoids on the course of early rheumatic arthritis].
    Suponitskaia EV; Smirnov AV; Aleksandrova EN; Novikov AA; Nasonov EL
    Klin Med (Mosk); 2004; 82(9):39-42. PubMed ID: 15540421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-α inhibitor in rheumatoid arthritis patients.
    Hjeltnes G; Hollan I; Førre Ø; Wiik A; Lyberg T; Mikkelsen K; Agewall S
    Scand J Rheumatol; 2012 May; 41(3):240-2. PubMed ID: 22401496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.